SCHEMBL128459

SCHEMBL128459

[CH2]Cc1ccc(C(=O)O)nc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 15/20 0.67
KDM4E B2RXH2 4/20 0.59
L3MBTL1 Q9Y468 3/20 0.59
ALDH1A1 P00352 2/20 0.59
KMT2A Q03164 2/20 0.59
HIF1A Q16665 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
MEN1 O00255 1/20 0.59
LMNA P02545 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
MAPT P10636 1/20 0.59
PKM P14618 1/20 0.59
ALOX15 P16050 1/20 0.59
TSHR P16473 1/20 0.59
NFKB1 P19838 1/20 0.59
THPO P40225 1/20 0.59
BLM P54132 1/20 0.59
PMP22 Q01453 1/20 0.59
P4HA1 P13674 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL287277 0.82 P4HTM (0.69) P4HTMKDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL2881907 0.80 P4HTM (0.67) P4HTMKDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL286868 0.80 KDM4E (0.69) P4HTMKDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL3965785 0.80 P4HTM (0.67) P4HTMKDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL15895251 0.80 P4HTM (0.67) P4HTMKDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL27589230 0.80 P4HTM (0.67) P4HTMKDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL10432643 0.79 P4HTM (0.62) P4HTMKDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL28108319 0.78 P4HTM (0.71) P4HTMKDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL127824 0.78 MAPK1 (0.59) P4HTMKDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL6434986 0.77 P4HTM (0.62) P4HTMKDM4EL3MBTL1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450319-B2 Pyrrolopyridazinone compound UBE INDUSTRIES, LTD. (JP) 2013-05-28 US disclosed
EP-1982986-B1 PYRROLOPYRIDAZINONE COMPOUND AS PDE4 INHIBITOR UBE INDUSTRIES (JP) 2012-03-07 EP disclosed
CN-101374844-A Pyrrolopyridazinone compound UBE INDUSTRIES (JP) 2009-02-25 CN disclosed
US-20090036453-A1 Pyrrolopyridazinone Compound UBE INDUSTRIES, LTD. (JP) 2009-02-05 US disclosed
EP-1982986-A1 PYRROLOPYRIDAZINONE COMPOUND Ube Industries, Ltd. (JP) 2008-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036453-A1 Pyrrolopyridazinone Compound CBR3, CBR1, CYC1 P4HTM 240/4885KDM4E 1902/4885L3MBTL1 2482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.